These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22773933)

  • 1. Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis.
    Tsikitis VL; Wertheim BC; Guerrero MA
    J Cancer; 2012; 3():292-302. PubMed ID: 22773933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016.
    Liu M; Wei L; Liu W; Chen S; Guan M; Zhang Y; Guo Z; Liu R; Xie P
    Front Oncol; 2023; 13():1079575. PubMed ID: 36776304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of patients with neuroendocrine tumor: a SEER database analysis.
    Man D; Wu J; Shen Z; Zhu X
    Cancer Manag Res; 2018; 10():5629-5638. PubMed ID: 30519109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.
    Ellis L; Shale MJ; Coleman MP
    Am J Gastroenterol; 2010 Dec; 105(12):2563-9. PubMed ID: 20823835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
    Modlin IM; Champaneria MC; Chan AK; Kidd M
    Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy.
    Gustafsson BI; Siddique L; Chan A; Dong M; Drozdov I; Kidd M; Modlin IM
    Int J Oncol; 2008 Dec; 33(6):1121-31. PubMed ID: 19020744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of neuroendocrine tumors and changing incidence in Kentucky.
    Chauhan A; Yu Q; Ray N; Farooqui Z; Huang B; Durbin EB; Tucker T; Evers M; Arnold S; Anthony LB
    Oncotarget; 2018 Apr; 9(27):19245-19254. PubMed ID: 29721198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia.
    Wyld D; Wan MH; Moore J; Dunn N; Youl P
    Cancer Epidemiol; 2019 Dec; 63():101598. PubMed ID: 31539715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.
    Allan B; Davis J; Perez E; Lew J; Sola J
    Eur J Pediatr Surg; 2013 Oct; 23(5):394-9. PubMed ID: 23444065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
    Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
    Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.
    Yang Z; Wang W; Lu J; Pan G; Pan Z; Chen Q; Liu W; Zhao Y
    Cell Physiol Biochem; 2018; 45(1):389-396. PubMed ID: 29402806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine.
    Keller HR; Senapathi SH; Morada A; Bertsch D; Cagir B
    Am J Surg; 2023 Jan; 225(1):58-65. PubMed ID: 36216612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?
    Fitzgerald TL; Dennis SO; Kachare SD; Vohra NA; Zervos EE
    Surgery; 2015 Aug; 158(2):466-71. PubMed ID: 26013986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased incidence of early onset colorectal adenocarcinoma is accompanied by an increased incidence of rectal neuroendocrine tumors.
    Lumsdaine CT; Liu-Smith F; Li X; Zell JA; Lu Y
    Am J Cancer Res; 2020; 10(6):1888-1899. PubMed ID: 32642298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated population-based review of carcinoid tumors.
    Maggard MA; O'Connell JB; Ko CY
    Ann Surg; 2004 Jul; 240(1):117-22. PubMed ID: 15213627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
    Navalkele P; O'Dorisio MS; O'Dorisio TM; Zamba GK; Lynch CF
    Pediatr Blood Cancer; 2011 Jan; 56(1):50-7. PubMed ID: 21108439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumor epidemiology: contrasting Norway and North America.
    Hauso O; Gustafsson BI; Kidd M; Waldum HL; Drozdov I; Chan AK; Modlin IM
    Cancer; 2008 Nov; 113(10):2655-64. PubMed ID: 18853416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
    Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
    Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
    Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
    PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Neuroendocrine Tumors in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States.
    Patel N; Benipal B
    Cureus; 2019 Mar; 11(3):e4322. PubMed ID: 31183301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.